Your browser doesn't support javascript.
loading
Diabetes and infectious disease mortality in Mexico City.
Bragg, Fiona; Kuri-Morales, Pablo; Berumen, Jaime; Garcilazo-Ávila, Adrián; Gonzáles-Carballo, Carlos; Ramírez-Reyes, Raúl; Santacruz-Benitez, Rogelio; Aguilar-Ramirez, Diego; Gnatiuc Friedrichs, Louisa; Herrington, William G; Hill, Michael; Trichia, Eirini; Wade, Rachel; Collins, Rory; Peto, Richard; Emberson, Jonathan R; Alegre-Diaz, Jesus; Tapia-Conyer, Roberto.
Affiliation
  • Bragg F; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Kuri-Morales P; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Berumen J; Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Garcilazo-Ávila A; Monterrey Institute of Technology and Higher Education, Nuevo Leon, Mexico.
  • Gonzáles-Carballo C; Experimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Ramírez-Reyes R; Experimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Santacruz-Benitez R; Experimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Aguilar-Ramirez D; Experimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Gnatiuc Friedrichs L; Experimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Herrington WG; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Hill M; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Trichia E; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Wade R; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Collins R; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Peto R; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Emberson JR; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Alegre-Diaz J; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Tapia-Conyer R; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Article in En | MEDLINE | ID: mdl-36889802
ABSTRACT

INTRODUCTION:

Although higher risks of infectious diseases among individuals with diabetes have long been recognized, the magnitude of these risks is poorly described, particularly in lower income settings. This study sought to assess the risk of death from infection associated with diabetes in Mexico. RESEARCH DESIGN AND

METHODS:

Between 1998 and 2004, a total of 159 755 adults ≥35 years were recruited from Mexico City and followed up until January 2021 for cause-specific mortality. Cox regression yielded adjusted rate ratios (RR) for death due to infection associated with previously diagnosed and undiagnosed (HbA1c ≥6.5%) diabetes and, among participants with previously diagnosed diabetes, with duration of diabetes and with HbA1c.

RESULTS:

Among 130 997 participants aged 35-74 and without other prior chronic diseases at recruitment, 12.3% had previously diagnosed diabetes, with a mean (SD) HbA1c of 9.1% (2.5%), and 4.9% had undiagnosed diabetes. During 2.1 million person-years of follow-up, 2030 deaths due to infectious causes were recorded at ages 35-74. Previously diagnosed diabetes was associated with an RR for death from infection of 4.48 (95% CI 4.05-4.95), compared with participants without diabetes, with notably strong associations with death from urinary tract (9.68 (7.07-13.3)) and skin, bone and connective tissue (9.19 (5.92-14.3)) infections and septicemia (8.37 (5.97-11.7)). In those with previously diagnosed diabetes, longer diabetes duration (1.03 (1.02-1.05) per 1 year) and higher HbA1c (1.12 (1.08-1.15) per 1.0%) were independently associated with higher risk of death due to infection. Even among participants with undiagnosed diabetes, the risk of death due to infection was nearly treble the risk of those without diabetes (2.69 (2.31-3.13)).

CONCLUSIONS:

In this study of Mexican adults, diabetes was common, frequently poorly controlled, and associated with much higher risks of death due to infection than observed previously, accounting for approximately one-third of all premature mortality due to infection.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Communicable Diseases / Diabetes Mellitus Type of study: Risk_factors_studies Limits: Adult / Humans Country/Region as subject: Mexico Language: En Journal: BMJ Open Diabetes Res Care Year: 2023 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Communicable Diseases / Diabetes Mellitus Type of study: Risk_factors_studies Limits: Adult / Humans Country/Region as subject: Mexico Language: En Journal: BMJ Open Diabetes Res Care Year: 2023 Document type: Article Affiliation country: Reino Unido